Old Web
English
Sign In
Acemap
>
Paper
>
12 weeks of sofosbuvir, daclatasvir and ribavirin for GT3 patients with cirrhosis
12 weeks of sofosbuvir, daclatasvir and ribavirin for GT3 patients with cirrhosis
2017
D. Troland
R Fox
J. Morris
M. Priest
M Heydtmann
S Barclay
Keywords:
Virology
Cirrhosis
Sofosbuvir
Daclatasvir
Ribavirin
Medicine
Gastroenterology
Internal medicine
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]